Yahoo
HKSE - Delayed Quote HKD

TATA Health International Holdings Limited (1255.HK)

1.825 0.000 (0.00%)
At close: October 26 at 9:42:01 AM GMT+8
Chart Range Bar
Loading chart for 1255.HK
  • Previous Close 1.825
  • Open 1.825
  • Bid 1.820 x --
  • Ask 1.825 x --
  • Day's Range 1.825 - 1.825
  • 52 Week Range 0.300 - 3.790
  • Volume 2,000
  • Avg. Volume 7,873
  • Market Cap (intraday) 443.192M
  • Beta (5Y Monthly) 1.81
  • PE Ratio (TTM) --
  • EPS (TTM) -0.030
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date Mar 18, 2015
  • 1y Target Est --

TATA Health International Holdings Limited, an investment holding company, engages in the wholesale and retail of footwear products in Hong Kong, and Macau. The company operates through Trading of Footwear Products, Trading of Healthcare Products, Financial Services, and Online Medical Services segments. The company was formerly known as S. Culture International Holdings Limited and changed its name to TATA Health International Holdings Limited in November 2020. TATA Health International Holdings Limited was incorporated in 2013 and is headquartered in Kwai Chung, Hong Kong. TATA Health International Holdings Limited is a subsidiary of Shang Ying Financial Holding Co., Limited.

www.s-culture.com

107

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

1255.HK
40.38%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

1255.HK
508.33%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

1255.HK
508.33%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

1255.HK
15.51%
HANG SENG INDEX (^HSI)
8.21%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.72%

  • Return on Assets (ttm)

    -14.92%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    97.55M

  • Net Income Avi to Common (ttm)

    -7.54M

  • Diluted EPS (ttm)

    -0.030

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    10.43M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -21.84M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: